Craig-Hallum analyst Chase Knickerbocker assigned a Buy rating to the stock today. The company’s shares closed last Friday at $8.20.
Knickerbocker covers the Healthcare sector, focusing on stocks such as Avadel Pharmaceuticals, Ironwood Pharma, and MiMedx Group. According to TipRanks, Knickerbocker has an average return of 16.7% and a 66.04% success rate on recommended stocks.
Currently, the analyst consensus on MiMedx Group is a Moderate Buy with an average price target of $12.00, representing a 46.34% upside. In a report released on February 12, Northland Securities also maintained a Buy rating on the stock with a $12.00 price target.
See today’s best-performing stocks on TipRanks >>
MDXG market cap is currently $954.3M and has a P/E ratio of -331.98.
Based on the recent corporate insider activity of 36 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MDXG in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
MiMedx Group (MDXG) Company Description:
MiMedx Group, Inc. is an advanced wound care and an emerging therapeutic biologics company. It engages in developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The company processes the human placental tissue utilizing its proprietary PURION process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx Group was founded on July 30, 1985 and is headquartered in Marietta, GA.
Read More on MDXG:
- MDXG Upcoming Earnings Report: What to Expect?
- MIMEDX to Present at TD Cowen 44th Annual Health Care Conference
- MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on February 28
- MiMedx management to meet with Craig Hallum
- MIMEDX Announces Improved Capital Structure with New Senior Secured Credit Facilities and Debt Refinancing
